Matthew Pollard

Person

Dural, AU

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CXCR2 antibodies and uses thereof
- Patent number 12,018,084
- Issue date Jun 25, 2024
- Cephalon LLC
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PAR-2 antibodies and methods of use thereof
- Patent number 11,725,052
- Issue date Aug 15, 2023
- Cephalon LLC
- Anna Mikaela Bracken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CXCR2 antibodies and uses thereof
- Patent number 11,332,534
- Issue date May 17, 2022
- Cephalon, Inc.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon alpha 2B variants
- Patent number 11,319,356
- Issue date May 3, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that specifically bind to human IL-15 and uses thereof
- Patent number 11,267,883
- Issue date Mar 8, 2022
- Cephalon, Inc.
- David Jose Simon Laine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TL1A and methods of treating r...
- Patent number 11,220,549
- Issue date Jan 11, 2022
- Cephalon, Inc.
- Lynn Dorothy Poulton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 11,117,975
- Issue date Sep 14, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 10,981,986
- Issue date Apr 20, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variants transmigrating the blood-brain barrier and uses t...
- Patent number 10,906,973
- Issue date Feb 2, 2021
- National Research Council of Canada
- Danica Stanimirovic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against TL1a and uses thereof
- Patent number 10,822,422
- Issue date Nov 3, 2020
- Teva Pharmaceuticals Australia Pty Ltd.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon alpha 2B variants
- Patent number 10,544,199
- Issue date Jan 28, 2020
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that specifically bind to TL1A
- Patent number 10,138,296
- Issue date Nov 27, 2018
- Cephalon, Inc.
- Lynn Dorothy Poulton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 9,963,515
- Issue date May 8, 2018
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 9,611,322
- Issue date Apr 4, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-23 heterodimer specific antibodies
- Patent number 9,127,057
- Issue date Sep 8, 2015
- Teva Pharmaceuticals Ausralia Pty Ltd
- Adam William Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies with anti-tumor activity
- Patent number 8,901,279
- Issue date Dec 2, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Adam W. Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanised antibodies with anti-tumour activity
- Patent number 8,470,320
- Issue date Jun 25, 2013
- Cephalon Australia Pty Ltd.
- Adam W. Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
- Publication number 20240301076
- Publication date Sep 12, 2024
- Cephalon LLC
- Doris Shim Siew Chen
- G01 - MEASURING TESTING
Information Patent Application
ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240150457
- Publication date May 9, 2024
- Cephalon LLC
- Anna Mikaela BRACKEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST TL1A AND USES THEREOF
- Publication number 20240141053
- Publication date May 2, 2024
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy POULTON
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
- Publication number 20220348671
- Publication date Nov 3, 2022
- Cephalon, Inc.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20220220184
- Publication date Jul 14, 2022
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies That Specifically Bind To TL1A
- Publication number 20220185902
- Publication date Jun 16, 2022
- Cephalon, Inc.
- Lynn Dorothy POULTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF
- Publication number 20220127352
- Publication date Apr 28, 2022
- Cephalon, Inc.
- David Jose Simon LAINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220056125
- Publication date Feb 24, 2022
- Cephalon, Inc.
- Anna Mikaela BRACKEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TL1A AND USES THEREOF
- Publication number 20210347904
- Publication date Nov 11, 2021
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy POULTON
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF
- Publication number 20200270339
- Publication date Aug 27, 2020
- Cephalon, Inc.
- David Jose Simon LAINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20200102364
- Publication date Apr 2, 2020
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIANTS TRANSMIGRATING THE BLOOD-BRAIN BARRIER AND USES T...
- Publication number 20200095316
- Publication date Mar 26, 2020
- National Research Council of Canada
- Danica Stanimirovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
- Publication number 20200040089
- Publication date Feb 6, 2020
- CEPHALON, INC.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies That Specifically Bind To TL1A
- Publication number 20190106486
- Publication date Apr 11, 2019
- Cephalon, Inc.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20180305460
- Publication date Oct 25, 2018
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA
- Publication number 20170233449
- Publication date Aug 17, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO TL1A
- Publication number 20170081400
- Publication date Mar 23, 2017
- Cephalon, Inc.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20160367695
- Publication date Dec 22, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against TL1a and Uses Thereof
- Publication number 20160333104
- Publication date Nov 17, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20160122410
- Publication date May 5, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20160068612
- Publication date Mar 10, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD1d
- Publication number 20140286957
- Publication date Sep 25, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Jonathan Kannan Nambiar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TL1a AND USES THEREOF
- Publication number 20140255302
- Publication date Sep 11, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy Poulton
- G01 - MEASURING TESTING
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20140248238
- Publication date Sep 4, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Humanized Antibodies with Anti-Tumor Activity
- Publication number 20130280246
- Publication date Oct 24, 2013
- Adam W. Clarke
- G01 - MEASURING TESTING
Information Patent Application
ANTI-IL-23 HETERODIMER SPECIFIC ANTIBODIES
- Publication number 20130115166
- Publication date May 9, 2013
- CEPHALON AUSTRALIA PTY LTD.
- Adam William Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANISED ANTIBODIES WITH ANTI-TUMOUR ACTIVITY
- Publication number 20100297134
- Publication date Nov 25, 2010
- CEPHALON AUSTRALIA PTY LTD
- Adam W. Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Matthew Pollard

Person

Patents Grantslast 30 patents

Anti-CXCR2 antibodies and uses thereof

Anti-PAR-2 antibodies and methods of use thereof

Anti-CXCR2 antibodies and uses thereof

Interferon alpha 2B variants

Antibodies that specifically bind to human IL-15 and uses thereof

Antibodies that specifically bind to TL1A and methods of treating r...

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Fusions of antibodies to CD38 and attenuated interferon alpha

Antibody variants transmigrating the blood-brain barrier and uses t...

Antibodies against TL1a and uses thereof

Interferon alpha 2B variants

Antibodies that specifically bind to TL1A

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Fusions of antibodies to CD38 and attenuated interferon alpha

Anti-IL-23 heterodimer specific antibodies

Humanized antibodies with anti-tumor activity

Humanised antibodies with anti-tumour activity

Patents Applicationslast 30 patents

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

INTERFERON ALPHA 2B VARIANTS

Antibodies That Specifically Bind To TL1A

ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF

INTERFERON ALPHA 2B VARIANTS

ANTIBODY VARIANTS TRANSMIGRATING THE BLOOD-BRAIN BARRIER AND USES T...

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

Antibodies That Specifically Bind To TL1A

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA

ANTIBODIES THAT SPECIFICALLY BIND TO TL1A

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

Antibodies Against TL1a and Uses Thereof

INTERFERON ALPHA 2B VARIANTS

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

ANTIBODIES TO CD1d

ANTIBODIES AGAINST TL1a AND USES THEREOF

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

Humanized Antibodies with Anti-Tumor Activity

ANTI-IL-23 HETERODIMER SPECIFIC ANTIBODIES

HUMANISED ANTIBODIES WITH ANTI-TUMOUR ACTIVITY